Korean Market
OTHR
Cellid
★

Appointment of 1 new outside director increases ratio from 33% to 50%

 
EXCH
Cellid
★

Extraordinary General Meeting Results: Articles Amendment, Outside Director Appointment Approved

 
OWNR
Cellid
★

CEO Changyul Kang acquires additional 4,300 shares via open market purchase (approx. KRW 13 million)

 
PERI
Cellid
★

Cellid Q1 2026: Liquidity Concerns, COVID Vaccine Setback, Pipeline Progress

 
EXCH
Cellid
★★★

Rejection of Phase 2 Clinical Trial Plan for COVID-19 Vaccine AdCLD-CoV19-1 LP.8.1

 
OWNR
Cellid
★

Executive/Major Shareholder Securities Ownership Report (No Change)

 
EXCH
Cellid
★

Finalized Investment of 23,544 Million Won for Magok Office (Correction Disclosure)

 
EXCH
Cellid
★

Seoul National University EGM Resolution Amendment - Electronic Voting & Outside Director Appointment

 
OWNR
Cellid
★

Cellid Announces AGM Agenda: Charter Amendments and New Outside Director Election

 
OTHR
Cellid
★★

Cellid: Agenda Includes E-Voting, Compliance with Revised Commercial Act, Appointment of Financial Expert Outside Director, and Remuneration Limits